BioSpace News Archive

MyChem’s nucleotide synthesis methods are highly complementary to Maravai’s TriLink mRNA technologies Increases capabilities serving the high-growth cell and gene therapy market.

Novoron Bioscience announced today that they have been awarded an NIA/NIH grant to advance their work into Alzheimer’s Disease (AD), chronic traumatic encephalopathy (CTE), and other tauopathies.

The registration recognizes I Peace’s cell manufacturing facility as suitable for drug manufacturing, based on detailed information submitted to the FDA.

Aesthetics combination therapy includes various approaches of treatment for bringing forth appealing and enhanced appearance in customers.

Bioprosthetics are the material obtained from human or other species for medical implantations.

Cosmetic dentistry refers to any work related to dental that changes and improves the look of a person’s gums and/or bite, teeth.

Critical and chronic care products are the branch of medicine concerned with the diagnosis and management of life-threatening conditions requiring sophisticated organ support and invasive monitoring whereas chronic care products refers to medical care products which addresses pre-existing or long term illness, as opposed to acute care which is concerned with diagnosis and treatment of short term or severe illness of brief duration.

Hospital information system is comprehensive information system designed to manage all the aspects of a hospital’s operation, such as administrative, medical, legal and financial concerns and the corresponding processing of services.

Mycobacteria is a large bacterial group, precisely a genus of actinobacteria, cause infections in humans.

Aurealis Therapeutics and Xbiome announced that the two companies have entered into an exclusive license and collaboration agreement for the clinical development and commercialization of Aurealis investigational Diabetic Foot Ulcer, other chronic wounds, and inflammatory disease therapy AUP-16 in Greater China.